NSUN5 and central nervous system cancer: We observed the enrichment of NSUN5 hypermethylation in low-grade gliomas (34%, 180 of 527) relative to GBM (6%, 10 of 154) (Fisher’s exact test, P = 3.8 10−9) (Fig. 7a).